I started at 252 pounds, and now Im at 204 pounds after five months of taking the pill and watching calories, writes one Reddit user
Moving forward, a concerted effort to include more representative populations in research is essential to fully understand how GLP-1-based treatments influence taste perception across all demographics
On May 15th, the journal Nature published a research paper titled "GLP-1-directed NMDA receptor antagonism for obesity treatment" by the Novo Nordisk team and the team led by Christoffer Clemmensen at the University of Copenhagen
Make eating a slow, mindful activity
Many also noted lower BMI and perceived health improvements
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial